title: Tumor suppressors control ULBP2, an innate surface ligand of the lymphocyte immune receptor NKG2D.
abstract: The activating receptor NKG2D, expressed on different innate and adaptive cytotoxic lymphocytes, has been demonstrated to play an important role in anti-tumor immunity. Now evidence is provided that tumor suppressors control expression of its ligand ULBP2 supporting the role of this receptor-ligand system as an innate barrier against tumor development.
authors: Department of Dermatology; University Hospital Essen; Essen, Germany.
authors: Anja
authors: A
authors: Heinemann
authors: Annette
authors: A
authors: Paschen